Please login to the form below

Not currently logged in
Email:
Password:

Merck

This page shows the latest Merck news and features for those working in and with pharma, biotech and healthcare.

Biogen and Eisai drop Alzheimer’s drug elenbecestat

Biogen and Eisai drop Alzheimer’s drug elenbecestat

Merck &Co/MSD, Janssen and Eli Lilly have all reported similar patterns in earlier failed candidates in the category.

Latest news

More from news
Approximately 363 fully matching, plus 1,303 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 9 fully matching, plus 128 partially matching documents found.

Latest appointments

More from appointments
Approximately 37 fully matching, plus 139 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 31 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

Alzheimers incidence
A roadmap to the successful treatment of Alzheimer’s disease
Building on past research to learn more about the disease and how to treat it...
Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...

Infographics